Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

Cognitive reactivity to sad mood provocation and the prediction of depressive relapse.

Segal ZV, Kennedy S, Gemar M, Hood K, Pedersen R, Buis T.

Arch Gen Psychiatry. 2006 Jul;63(7):749-55.

PMID:
16818864
2.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
3.

Outcomes in major depressive disorder: the evolving concept of remission and its implications for treatment.

Möller HJ.

World J Biol Psychiatry. 2008;9(2):102-14. doi: 10.1080/15622970801981606. Review.

PMID:
18428079
4.

[Severe depression : psychological aspects of management].

André C.

Encephale. 2009 Dec;35 Suppl 7:S330-4. doi: 10.1016/S0013-7006(09)73497-9. Review. French.

PMID:
20141798
5.

Long-term effectiveness of cognitive therapy in major depressive disorder.

Hensley PL, Nadiga D, Uhlenhuth EH.

Depress Anxiety. 2004;20(1):1-7. Review.

PMID:
15368590
6.

The Treatment for Adolescents With Depression Study (TADS): demographic and clinical characteristics.

Treatment for Adolescents with Depression Study (TADS) Team.

J Am Acad Child Adolesc Psychiatry. 2005 Jan;44(1):28-40. Review.

PMID:
15608541
7.

Remission onset and relapse in depression. An 18-month prospective study of course for 100 first admission patients.

O'Leary D, Costello F, Gormley N, Webb M.

J Affect Disord. 2000 Jan-Mar;57(1-3):159-71. Review.

PMID:
10708827
8.

[Cholinesterase inhibitors and depression in the elderly].

Amara G, Saada W, Ben Nasr S, Ben Hadj Ali B.

Encephale. 2010 Feb;36(1):77-81. doi: 10.1016/j.encep.2009.02.004. Epub 2009 Aug 31. Review. French.

PMID:
20159200
9.

Rationale for, barriers to, and appropriate medication for the long-term treatment of depression.

Nutt DJ.

J Clin Psychiatry. 2010;71 Suppl E1:e02. doi: 10.4088/JCP.9058se1c.02gry.

PMID:
20371029
10.
11.

Course and outcomes of depression in the elderly.

Kohn R, Epstein-Lubow G.

Curr Psychiatry Rep. 2006 Feb;8(1):34-40. Review.

PMID:
16513041
12.

The effects of tryptophan depletion on mood and psychiatric symptoms.

Van der Does AJ.

J Affect Disord. 2001 May;64(2-3):107-19. Review.

PMID:
11313078
13.

An approach to managing depression. Defining and measuring outcomes.

Khullar A, McIntyre RS.

Can Fam Physician. 2004 Oct;50:1374-80. Review.

14.

[Residual symptoms and recurrence in major depressive disorder].

Spadone C, Corruble E.

Encephale. 2010 Dec;36 Suppl 5:S108-11. doi: 10.1016/S0013-7006(10)70040-3. Review. French.

PMID:
21211628
15.

Pathophysiologic aspects of major depression following traumatic brain injury.

Jorge RE, Starkstein SE.

J Head Trauma Rehabil. 2005 Nov-Dec;20(6):475-87. Review.

PMID:
16304485
16.

Poststroke depression: prevalence, diagnosis, treatment, and disease progression.

Robinson RG.

Biol Psychiatry. 2003 Aug 1;54(3):376-87. Review.

PMID:
12893112
17.

[Recurrent depression in the elderly: what cognitive prognosis?].

Benoit M.

Encephale. 2010 Dec;36 Suppl 5:S132-5. doi: 10.1016/S0013-7006(10)70045-2. Review. French.

PMID:
21211633
18.

Cognitive-behavioral therapy for depression.

Mor N, Haran D.

Isr J Psychiatry Relat Sci. 2009;46(4):269-73. Review.

19.

Enhancing the efficacy of antidepressants with psychotherapy.

Petersen TJ.

J Psychopharmacol. 2006 May;20(3 Suppl):19-28. Review.

PMID:
16644768
20.

[What is the contribution of clinical practice recommendations concerning the prevention of depressive recurrences?].

Llorca PM.

Encephale. 2010 Dec;36 Suppl 5:S150-4. doi: 10.1016/S0013-7006(10)70049-X. Review. French.

PMID:
21211637
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk